Spotlight on atezolizumab and its potential in the treatment of advanced urothelial bladder cancer
Ahmet Murat Aydin,1,* Solomon L Woldu,1,* Ryan C Hutchinson,1 Martin Boegemann,2 Aditya Bagrodia,1 Yair Lotan,1 Vitaly Margulis,1 Laura-Maria Krabbe1,2 1Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA; 2Department of Urology, University of Münster Me...
Main Authors: | Aydin AM, Woldu SL, Hutchinson RC, Boegemann M, Bagrodia A, Lotan Y, Margulis V, Krabbe LM |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2017-03-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/spotlight-on-atezolizumab-and-its-potential-in-the-treatment-of-advanc-peer-reviewed-article-OTT |
Similar Items
-
Experience of using atezolizumab in 1st line therapy of metastatic urothelial cancer
by: R. A. Gafanov, et al.
Published: (2019-10-01) -
Biomarkers for immunotherapy in bladder cancer: a moving target
by: David H. Aggen, et al.
Published: (2017-11-01) -
A Case of Pseudoprogression During Atezolizumab Therapy
in Lung Adenocarcinoma
by: Xue WANG, et al.
Published: (2019-06-01) -
MODERN POSSIBILITIES OF THERAPY WITH INHIBITORS OF CONTROL POINTS IN METASTATIC UROTHELIAL CANCER
by: R. A. Gafanov, et al.
Published: (2018-03-01) -
Bladder preservation therapy in combination with atezolizumab and radiation therapy for invasive bladder cancer (BPT-ART) – A study protocol for an open-label, phase II, multicenter study
by: Yuta Sekino, et al.
Published: (2021-03-01)